New stent device aims to better seal brain aneurysms
NCT ID NCT07372612
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a newer flow-diverting stent to standard stent-assisted coiling for treating unruptured brain aneurysms in the middle cerebral artery. About 140 adults aged 18-70 will be randomly assigned to one of the two procedures. The main goal is to see which method more completely closes the aneurysm and reduces the chance of it coming back, while also checking safety and neurological function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Flow diverter device (Lattice stent) with optional coiling
- What this could lead to
- If successful, this could establish a more effective treatment for certain brain aneurysms, reducing the chance of recurrence and improving patient outcomes.
- What could go wrong
- This is a single-center Phase 4 trial with 140 participants, so results may not apply broadly. Both procedures carry risks like bleeding or stroke, and the flow diverter may not prove superior.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEURYSMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict which heart aneurysms will grow?
- Brain aneurysm showdown: which coated stent causes fewer strokes?
- Massive study aims to predict brain surgery success
- Brain aneurysm showdown: which treatment works best?
- New stent study aims to seal brain aneurysms without open surgery
- Could a simple steroid prevent strokes after brain aneurysm stenting?